Cargando…
A longitudinal model for disease progression was developed and applied to multiple sclerosis
OBJECTIVES: To develop a model of disease progression using multiple sclerosis (MS) as an exemplar. STUDY DESIGN AND SETTINGS: Two observational cohorts, the University of Wales MS (UoWMS), UK (1976), and British Columbia MS (BCMS) database, Canada (1980), with longitudinal disability data [the Expa...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4643305/ https://www.ncbi.nlm.nih.gov/pubmed/26071892 http://dx.doi.org/10.1016/j.jclinepi.2015.05.003 |
_version_ | 1782400502583001088 |
---|---|
author | Lawton, Michael Tilling, Kate Robertson, Neil Tremlett, Helen Zhu, Feng Harding, Katharine Oger, Joel Ben-Shlomo, Yoav |
author_facet | Lawton, Michael Tilling, Kate Robertson, Neil Tremlett, Helen Zhu, Feng Harding, Katharine Oger, Joel Ben-Shlomo, Yoav |
author_sort | Lawton, Michael |
collection | PubMed |
description | OBJECTIVES: To develop a model of disease progression using multiple sclerosis (MS) as an exemplar. STUDY DESIGN AND SETTINGS: Two observational cohorts, the University of Wales MS (UoWMS), UK (1976), and British Columbia MS (BCMS) database, Canada (1980), with longitudinal disability data [the Expanded Disability Status Scale (EDSS)] were used; individuals potentially eligible for MS disease-modifying drugs treatments, but who were unexposed, were selected. Multilevel modeling was used to estimate the EDSS trajectory over time in one data set and validated in the other; challenges addressed included the choice and function of time axis, complex observation-level variation, adjustments for MS relapses, and autocorrelation. RESULTS: The best-fitting model for the UoWMS cohort (404 individuals, and 2,290 EDSS observations) included a nonlinear function of time since onset. Measurement error decreased over time and ad hoc methods reduced autocorrelation and the effect of relapse. Replication within the BCMS cohort (978 individuals and 7,335 EDSS observations) led to a model with similar time (years) coefficients, time [0.22 (95% confidence interval {CI}: 0.19, 0.26), 0.16 (95% CI: 0.10, 0.22)] and log time [−0.13 (95% CI: −0.39, 0.14), −0.15 (95% CI: −0.70, 0.40)] for BCMS and UoWMS, respectively. CONCLUSION: It is possible to develop robust models of disability progression for chronic disease. However, explicit validation is important given the complex methodological challenges faced. |
format | Online Article Text |
id | pubmed-4643305 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-46433052015-12-08 A longitudinal model for disease progression was developed and applied to multiple sclerosis Lawton, Michael Tilling, Kate Robertson, Neil Tremlett, Helen Zhu, Feng Harding, Katharine Oger, Joel Ben-Shlomo, Yoav J Clin Epidemiol Original Article OBJECTIVES: To develop a model of disease progression using multiple sclerosis (MS) as an exemplar. STUDY DESIGN AND SETTINGS: Two observational cohorts, the University of Wales MS (UoWMS), UK (1976), and British Columbia MS (BCMS) database, Canada (1980), with longitudinal disability data [the Expanded Disability Status Scale (EDSS)] were used; individuals potentially eligible for MS disease-modifying drugs treatments, but who were unexposed, were selected. Multilevel modeling was used to estimate the EDSS trajectory over time in one data set and validated in the other; challenges addressed included the choice and function of time axis, complex observation-level variation, adjustments for MS relapses, and autocorrelation. RESULTS: The best-fitting model for the UoWMS cohort (404 individuals, and 2,290 EDSS observations) included a nonlinear function of time since onset. Measurement error decreased over time and ad hoc methods reduced autocorrelation and the effect of relapse. Replication within the BCMS cohort (978 individuals and 7,335 EDSS observations) led to a model with similar time (years) coefficients, time [0.22 (95% confidence interval {CI}: 0.19, 0.26), 0.16 (95% CI: 0.10, 0.22)] and log time [−0.13 (95% CI: −0.39, 0.14), −0.15 (95% CI: −0.70, 0.40)] for BCMS and UoWMS, respectively. CONCLUSION: It is possible to develop robust models of disability progression for chronic disease. However, explicit validation is important given the complex methodological challenges faced. Elsevier 2015-11 /pmc/articles/PMC4643305/ /pubmed/26071892 http://dx.doi.org/10.1016/j.jclinepi.2015.05.003 Text en Crown Copyright © Published by Elsevier Inc. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which allows reusers to copy and distribute the material in any medium or format in unadapted form only, for noncommercial purposes only, and only so long as attribution is given to the creator. |
spellingShingle | Original Article Lawton, Michael Tilling, Kate Robertson, Neil Tremlett, Helen Zhu, Feng Harding, Katharine Oger, Joel Ben-Shlomo, Yoav A longitudinal model for disease progression was developed and applied to multiple sclerosis |
title | A longitudinal model for disease progression was developed and applied to multiple sclerosis |
title_full | A longitudinal model for disease progression was developed and applied to multiple sclerosis |
title_fullStr | A longitudinal model for disease progression was developed and applied to multiple sclerosis |
title_full_unstemmed | A longitudinal model for disease progression was developed and applied to multiple sclerosis |
title_short | A longitudinal model for disease progression was developed and applied to multiple sclerosis |
title_sort | longitudinal model for disease progression was developed and applied to multiple sclerosis |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4643305/ https://www.ncbi.nlm.nih.gov/pubmed/26071892 http://dx.doi.org/10.1016/j.jclinepi.2015.05.003 |
work_keys_str_mv | AT lawtonmichael alongitudinalmodelfordiseaseprogressionwasdevelopedandappliedtomultiplesclerosis AT tillingkate alongitudinalmodelfordiseaseprogressionwasdevelopedandappliedtomultiplesclerosis AT robertsonneil alongitudinalmodelfordiseaseprogressionwasdevelopedandappliedtomultiplesclerosis AT tremletthelen alongitudinalmodelfordiseaseprogressionwasdevelopedandappliedtomultiplesclerosis AT zhufeng alongitudinalmodelfordiseaseprogressionwasdevelopedandappliedtomultiplesclerosis AT hardingkatharine alongitudinalmodelfordiseaseprogressionwasdevelopedandappliedtomultiplesclerosis AT ogerjoel alongitudinalmodelfordiseaseprogressionwasdevelopedandappliedtomultiplesclerosis AT benshlomoyoav alongitudinalmodelfordiseaseprogressionwasdevelopedandappliedtomultiplesclerosis AT lawtonmichael longitudinalmodelfordiseaseprogressionwasdevelopedandappliedtomultiplesclerosis AT tillingkate longitudinalmodelfordiseaseprogressionwasdevelopedandappliedtomultiplesclerosis AT robertsonneil longitudinalmodelfordiseaseprogressionwasdevelopedandappliedtomultiplesclerosis AT tremletthelen longitudinalmodelfordiseaseprogressionwasdevelopedandappliedtomultiplesclerosis AT zhufeng longitudinalmodelfordiseaseprogressionwasdevelopedandappliedtomultiplesclerosis AT hardingkatharine longitudinalmodelfordiseaseprogressionwasdevelopedandappliedtomultiplesclerosis AT ogerjoel longitudinalmodelfordiseaseprogressionwasdevelopedandappliedtomultiplesclerosis AT benshlomoyoav longitudinalmodelfordiseaseprogressionwasdevelopedandappliedtomultiplesclerosis |